Patent US4663337A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4663337A Expired / Lapsed US ⏱️ 0.0 years remaining

7-oxabicycloheptane substituted amides useful in the treatment of thrombotic disease

Assignee: ER Squibb and Sons LLC
•
Filing: 1986-04-18
•
Granted: 1987-05-05
•
Expires: 2006-04-18
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract 7-Oxabicycloheptane substituted amides are provided having the structural formula ##STR1## wherein m is 0 to 4; A is --CH═CH-- or --CH 2 --CH 2 --; n is 1 to 5; R is CO 2 H, CO 2 alkyl, CO 2 alkali metal, CO 2 polyhydroxyamine salt, ##STR2## wherein R 4 and R 5 are the same or different and are H, lower alkyl, hydroxy, lower alkoxy or aryl, at least one of R 4 and R 5 being other than hydroxy and lower alkoxy; R 1 is H, lower alkyl or aryl; q is 1 to 6; X is ##STR3## (wherein q is 1) or ##STR4## (wherein R 3 is H or lower alkyl); R 2 is lower alkyl, lower alkenyl, lower alkynyl, aryl, arylalkyl, lower alkoxy, aralkyloxy, cycloalkyl or cycloalkylalkyl. The compounds are cardiovascular agents useful, for example, in the treatment of thrombotic disease.

Inventors

  • 👤 Jagabandhu Das
  • 👤 Masami Nakane

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-27 13:25
CPC Classifications
C; C07; C07D; C07D493/00; C07D493/02; C07D493/08

Claims Analysis

Total Claims: 19
Claim 1
Independent Claim 420 words
A compound having the structure ##STR99## including all stereoisomers thereof, wherein m is 0 to 4; A is --CH═CH-- or --CH 2 --CH 2 --; n is 1 to 5; R is CO 2 H, CO 2 alkyl, CO 2 alkali metal, CO 2 polyhydroxyamine salt ##STR100## wherein R 4 and R 5 are the same or different and are H, lower alkyl, hydroxy, lower alkoxy or aryl at least one of R 4 and R 5 being other than hydroxy and lower alkoxy; R 1 is H, lower alkyl or aryl; q is 1 to 6; X is ##STR101## wherein R 3 is H or lower alkyl; and R 2 is lower alkyl, lower alkenyl containing 2 to 12 carbons, lower alkynyl containing 2 to 12 carbons, aryl, arylalkyl, lower alkoxy, aralkyloxy, cycloalkyl or cycloalkylalkyl, with the proviso that when X is ##STR102## q is 1; (CH 2 ) m and (CH 2 ) n may be unsubstituted or substituted with 1 or 2 lower alkyl groups and/or 1 or 2 halogens; (CH 2 ) q may be unsubstituted or substituted by 1 or 2 halo, hydroxy, alkoxy, amine, alkylamine, arylamine, thiol, alkylthio, arylthio, cyano, or nitro groups; wherein lower alkyl or alkyl alone or as part of another group containing 1 to 12 carbons and is unsubstituted or is substituted with halo, CF 3 , alkoxy, aryl, alkyl-aryl, haloaryl, cycloalkyl, alkylcycloalkyl, hydroxy, alkylamino, alkanoylamino, arylcarbonylamino, nitro, cyano, thiol or alkylthio; aryl alone or as part of another group contains 6 to 10 carbons in the ring portion and is unsubstituted or is substituted with 1 or 2 lower alkyl groups, 1 or 2 halogens, 1 or 2 alkoxy groups, 1 or 2 hydroxy groups, 1 or 2 alkylamino groups, 1 or 2 alkanoylamino groups, 1 or 2 arylcarbonylamino groups, 1 or 2 amino groups, 1 or 2 nitro groups, 1 or 2 cyano groups, 1 or 2 thiol groups and/or 1 or 2 alkylthio groups; cycloalkyl alone or as part of another group contains 3 to 12 carbons and is unsubstituted or is substituted with 1 or 2 halogens, 1 or 2 lower alkyl groups, 1 or 2 lower alkoxy groups, 1 or 2 hydroxy groups, 1 or 2 alkylamino groups, 1 or 2 alkanoylamino groups, 1 or 2 arylcarbonylamino groups, 1 or 2 amino groups, 1 or 2 nitro groups, 1 or 2 cyano groups, 1 or 2 thiol groups and/or 1 or 2 alkylthio groups; and alkanoyl refers to lower alkyl linked to a carbonyl group.
Claim 2
Dependent Claim 420 words
A compound having the structure ##STR99## including all stereoisomers thereof, wherein m is 0 to 4; A is --CH═CH-- or --CH 2 --CH 2 --; n is 1 to 5; R is CO 2 H, CO 2 alkyl, CO 2 alkali metal, CO 2 polyhydroxyamine salt ##STR100## wherein R 4 and R 5 are the same or different and are H, lower alkyl, hydroxy, lower alkoxy or aryl at least one of R 4 and R 5 being other than hydroxy and lower alkoxy; R 1 is H, lower alkyl or aryl; q is 1 to 6; X is ##STR101## wherein R 3 is H or lower alkyl; and R 2 is lower alkyl, lower alkenyl containing 2 to 12 carbons, lower alkynyl containing 2 to 12 carbons, aryl, arylalkyl, lower alkoxy, aralkyloxy, cycloalkyl or cycloalkylalkyl, with the proviso that when X is ##STR102## q is 1; (CH 2 ) m and (CH 2 ) n may be unsubstituted or substituted with 1 or 2 lower alkyl groups and/or 1 or 2 halogens; (CH 2 ) q may be unsubstituted or substituted by 1 or 2 halo, hydroxy, alkoxy, amine, alkylamine, arylamine, thiol, alkylthio, arylthio, cyano, or nitro groups; wherein lower alkyl or alkyl alone or as part of another group containing 1 to 12 carbons and is unsubstituted or is substituted with halo, CF 3 , alkoxy, aryl, alkyl-aryl, haloaryl, cycloalkyl, alkylcycloalkyl, hydroxy, alkylamino, alkanoylamino, arylcarbonylamino, nitro, cyano, thiol or alkylthio; aryl alone or as part of another group contains 6 to 10 carbons in the ring portion and is unsubstituted or is substituted with 1 or 2 lower alkyl groups, 1 or 2 halogens, 1 or 2 alkoxy groups, 1 or 2 hydroxy groups, 1 or 2 alkylamino groups, 1 or 2 alkanoylamino groups, 1 or 2 arylcarbonylamino groups, 1 or 2 amino groups, 1 or 2 nitro groups, 1 or 2 cyano groups, 1 or 2 thiol groups and/or 1 or 2 alkylthio groups; cycloalkyl alone or as part of another group contains 3 to 12 carbons and is unsubstituted or is substituted with 1 or 2 halogens, 1 or 2 lower alkyl groups, 1 or 2 lower alkoxy groups, 1 or 2 hydroxy groups, 1 or 2 alkylamino groups, 1 or 2 alkanoylamino groups, 1 or 2 arylcarbonylamino groups, 1 or 2 amino groups, 1 or 2 nitro groups, 1 or 2 cyano groups, 1 or 2 thiol groups and/or 1 or 2 alkylthio groups; and alkanoyl refers to lower alkyl linked to a carbonyl group.
Claim 3
Dependent Claim 16 words
The compound is defined in claim 1 wherein R 1 is H and q is 1.
Claim 4
Dependent Claim 11 words
The compound as defined in claim 1 wherein A is CH═CH.
Claim 5
Dependent Claim 17 words
The compound as defined in claim 1 wherein m is 1 and n is 1 to 4.
Claim 6
Dependent Claim 15 words
The compound as defined in claim 1 wherein X is ##STR103## and q is 1.
Claim 7
Dependent Claim 11 words
The compound as defined in claim 1 wherein X is ##STR104##
Claim 8
Dependent Claim 17 words
The compound as defined in claim 1 wherein R is CO 2 alkyl or CO 2 H.
Claim 9
Dependent Claim 42 words
The compound as defined in claim 1 wherein R 1 is H and R 2 is C 4 H 9 , C 5 H 11 , C 6 H 13 , C 7 H 15 , C 6 H 5 , ##STR105##
Claim 10
Dependent Claim 49 words
The compound as defined in claim 1 wherein m is 1, n is 2 to 4, R is CO 2 alkyl, CO 2 H, CH 2 OH, or ##STR106## R 1 is H, q is 1, X is --CH 2 -- or ##STR107## R 2 is alkyl or hydroxyphenyl.
Claim 11
Dependent Claim 20 words
The compound as defined in claim 1 having the name [1β,2α(5Z), 3α,4β]-7-[3-[[[2-(heptylamino)-2-oxoethyl]-amino]carbonyl]-7-oxabicyclo[2.2.1]hept-2-yl]-5-heptenoic acid or esters thereof, including all stereoisomers thereof.
Claim 12
Dependent Claim 19 words
The compound as defined in claim 1 having the name [1β,2α(5Z),3α,4β]-7-[3-[[[3-(hexylamino)-3-oxopropyl]-amino]carbonyl]-7-oxabicyclo[2.2.1]hept-2-yl]-5-heptenoic acid or esters thereof, including all stereoisomers thereof.
Claim 13
Dependent Claim 19 words
The compound as defined in claim 1 having the name [1β,2α(5Z),3α(R),4β]-7-[3-[[(3-phenylpropyl)amino]carbonyl]-7-oxabicyclo[2.2.1]hept-2-yl]-5-heptenoic acid or esters thereof, including all stereoisomers thereof.
Claim 14
Dependent Claim 19 words
The compound as defined in claim 1 having the name [1β,2α(5Z),3α(R),4β]-7-[3-[[[2-[(4-hydroxyphenyl)amino]-2-oxoethyl]amino]carbonyl]-7-oxabicyclo[2.2.1]hept-2-yl]-5-heptenoic acid, or esters thereof, including all stereoisomers thereof.
Claim 15
Dependent Claim 13 words
The compound as defined in claim 1 having the name [1β,2α(5Z), 3α,4β]-7-[3-[[2-hydroxypentyl)amino]carbonyl]-7-oxabicyclo[2.2.1]hept-2-yl]-5-heptenoic acid.
Claim 16
Dependent Claim 36 words
A method of inhibiting platelet aggregation and bronchoconstriction, which comprises administering to the circulatory system of a mammalian host an effective amount of a compound as defined in claim 1 or a pharmaceutically acceptable salt thereof.
Claim 17
Dependent Claim 26 words
The method as defined in claim 15 wherein said compound is administered in an amount within the range of from about 0.1 to about 100 mg/kg.
Claim 18
Dependent Claim 32 words
A composition for inhibiting platelet aggregation and bronchoconstriction comprising an effective amount of a compound as defined in claim 1 or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier therefor.
Claim 19
Dependent Claim 34 words
A method of treating peripheral vascular diseases, which comprises topically or systemically administering to a mammalian host an effective amount of a compound as defined in claim 1 or a pharmaceutically acceptable salt thereof.

References Cited (Backward Citations)

US4143054A Cited
US4187236A Cited
US4220594A Cited
US4254044A Cited
GB2039909A Cited
US4228180A Cited
EP0043292A2 Cited
EP0082646A1 Cited
US4416896A Cited
US4456617A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1990-05-04 1990-11-03 1991-05-05 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1994-05-04 1994-11-03 1995-05-05 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1998-05-04 1998-11-03 1999-05-05 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag